AR003089A1 - USE OF COLECALCIFEROL DERIVATIVES. - Google Patents

USE OF COLECALCIFEROL DERIVATIVES.

Info

Publication number
AR003089A1
AR003089A1 ARP960104895A ARP960104895A AR003089A1 AR 003089 A1 AR003089 A1 AR 003089A1 AR P960104895 A ARP960104895 A AR P960104895A AR P960104895 A ARP960104895 A AR P960104895A AR 003089 A1 AR003089 A1 AR 003089A1
Authority
AR
Argentina
Prior art keywords
colecalciferol
derivatives
bone density
treat
hexafluorocholecalciferol
Prior art date
Application number
ARP960104895A
Other languages
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR003089A1 publication Critical patent/AR003089A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición farmacéutica para tratar la osteoporosis o para tratar una condición médica caracterizada por una disminución en la densidad ósea,restaurando la densidad ósea hasta un nivel asintomático, sin inducir la hipercalciuria, hipercalcemia, o nefrotoxicidad, dicha composición contiene alcompuesto 1alfa-fluor-25-hidroxi-16-ene-23-ine-26,27- hexafluorocolecalciferol, como ingrediente activo.A pharmaceutical composition to treat osteoporosis or to treat a medical condition characterized by a decrease in bone density, restoring bone density to an asymptomatic level, without inducing hypercalciuria, hypercalcemia, or nephrotoxicity, said composition contains the compound 1alpha-fluor-25 -hydroxy-16-ene-23-ine-26,27-hexafluorocholecalciferol, as active ingredient.

ARP960104895A 1995-10-27 1996-10-24 USE OF COLECALCIFEROL DERIVATIVES. AR003089A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US596695P 1995-10-27 1995-10-27

Publications (1)

Publication Number Publication Date
AR003089A1 true AR003089A1 (en) 1998-07-08

Family

ID=21718613

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104895A AR003089A1 (en) 1995-10-27 1996-10-24 USE OF COLECALCIFEROL DERIVATIVES.

Country Status (4)

Country Link
AR (1) AR003089A1 (en)
AU (1) AU7295696A (en)
WO (1) WO1997016193A1 (en)
ZA (1) ZA969021B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
ES2192136B1 (en) * 2002-01-04 2005-03-16 Italfarmaco, S.A. PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF OSTEOPOROSIS.
CN114588176B (en) * 2022-02-15 2024-01-23 许静宜 Method for researching ophiopogonin D to promote osteoporosis H-type blood vessel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
DK0580968T3 (en) * 1992-05-20 1996-10-14 Hoffmann La Roche Fluorinated analogs of vitamin D3

Also Published As

Publication number Publication date
AU7295696A (en) 1997-05-22
WO1997016193A1 (en) 1997-05-09
ZA969021B (en) 1998-04-28

Similar Documents

Publication Publication Date Title
ES2088312T3 (en) CONTROLLED RELEASE FORMULATION CONTAINING TRAMADOL.
ES2064130T3 (en) USE OF DROLOXIFENO FOR THE TREATMENT OF DISEASES OF THE BONES.
BR0009830A (en) Skin care compositions containing a combination of active substances for skin care
ES2129048T3 (en) STABILIZED COMPOSITION OF PARATHYROID HORMONE.
AR240250A1 (en) PROCEDURE FOR THE PREPARATION OF A NEW ORAL PHARMACEUTICAL FORMULATION CONTAINING OMEPRAZOLE AS AN ACTIVE INGREDIENT.
ES2156603T3 (en) MEDICATIONS BASED ON A SYNTHETIC MIXTURE OF METRONIDAZOL AND CLINDAMYCIN.
MX9701416A (en) Surface-active formulations.
DK0517797T3 (en) Use of vitamin D analogues in the treatment of acne
BR9503406A (en) Pharmaceutical formulations adapted to inhibit bone loss in a human
AR240225A1 (en) INSECTICIDE COMPOSITION THAT INCLUDES MORE THAN ONE ACTIVE COMPOUND.
ATE260650T1 (en) ORAL DOSAGE FORMS FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
DK1121127T3 (en) Oral pharmaceutical compositions containing buprenorphine
SV2001000125A (en) PROCEDURE FOR THE OBTAINING OF SOLID PHARMACEUTICAL PREPARATIONS FOR QUICK DISGREGATION REF.LEA 33801-SV
ECSP930933A (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR PREPARING IT
AR018162A1 (en) SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION
AR003089A1 (en) USE OF COLECALCIFEROL DERIVATIVES.
AR046402A1 (en) COMBINATION OF ACTIVE PRINCIPLE THAT INCLUDES A 2,5-DIHYDROBENCENOSULPHONIC COMPOUND AND A POTASSIUM CHANNEL MODULATOR
BRPI0414114A (en) defibrotide use, formulation, and, method for treating a mammal affected by a tumor
ES2129448T3 (en) USE OF 2- (2-NITRO-4-TRIFLUOROMETILBENZOIL) -1,3-CYCLLOHEXANODIONA IN THE TREATMENT OF THYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS.
DK0469440T3 (en) Solid oral dosage forms containing as active ingredient ifosamide
AR023177A1 (en) A CLEANING PAD FOR TOILETS.
ES2172332T3 (en) USE OF ISOOSMOTIC SALT SOLUTIONS FOR THE PREPARATION OF CERUMENOLITICAL MEDICINES.
ECSP003551A (en) PHARMACEUTICAL COMPLEX
BR0114289A (en) Compositions For Skin Cleansing And Acne Treatment
ATE234096T1 (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION CONTAINING THE ACTIVE INGREDIENT MORPHINE-6-GLUCURONIDE